EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieKlinische Studie (Phase I)Open access

Patient-Centered mHealth Intervention to Improve Self-Care in Patients With Chronic Heart Failure: Phase 1 Randomized Controlled Trial

Patientenzentrierte mHealth-Intervention zur Verbesserung der Selbstfürsorge bei Patient:innen mit chronischer Herzinsuffizienz: randomisierte Studie der Phase 1

Spyros Kitsiou iD, Ben S Gerber iD, Susan W Buchholz iD, Mayank M Kansal iD, Jiehuan Sun iD, Susan J Pressler iD

Journal of Medical Internet Research · 2025-01-15 · 27 · e55586

DOI: 10.2196/55586 ↗

Auf einen Blick

In einer randomisierten Studie war iCardia4HF machbar, akzeptabel und sicher. Die Änderungen der Selbstfürsorge-Scores fielen nach 8 Wochen zugunsten der Intervention aus, die Effekte waren klein.

Fragestellung

Ist die patientenzentrierte mHealth-Intervention iCardia4HF bei Patient:innen mit Herzinsuffizienz machbar, akzeptabel, sicher und vorläufig wirksam?

Methode

Randomisierte kontrollierte Phase-1-Studie; 8 Wochen Beobachtung; iCardia4HF plus übliche Versorgung versus nur übliche Versorgung.

Ergebnisse

27 Patient:innen wurden randomisiert (13 vs. 14); 11 vs. 14 gingen in die Vollanalyse ein. Hohe Retention und Adhärenz >80 %. SCHFI-Änderungen zugunsten der Intervention: maintenance d=0,19 (95 %-KI –0,65 bis 1,02), symptom perception d=0,33 (95 %-KI –0,51 bis 1,17), self-care management d=0,25 (95 %-KI –0,55 bis 1,04).

Schlussfolgerung der Autor:innen

iCardia4HF war machbar, akzeptabel und sicher. Eine größere Studie mit längerer Nachbeobachtung ist nötig, um die Wirksamkeit bei Herzinsuffizienz zu prüfen.

Kernaussagen

  • Hohe Retention, Studienvisiten und tägliche Selbstmessung >80 %
  • Keine unerwünschten Ereignisse durch die Intervention
  • Vorläufige Effekte zugunsten der Intervention, aber klein

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Randomisierte kontrollierte Studie in Journal of Medical Internet Research, published online on 2025-01-15. Written by Spyros Kitsiou and 5 co-authors. Institution: University of Illinois Chicago, Chicago, IL, United States. Major MEDLINE topics: Heart Failure, Self Care, Telemedicine, Patient-Centered Care. Cited 31 times so far (Crossref); 115 references. The full text is freely available in PubMed Central. Funded by: NIA NIH HHS, NCATS NIH HHS.

Auf einen BlickAbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Heart failure (HF) is one of the most common causes of hospital readmission in the United States. These hospitalizations are often driven by insufficient self-care. Commercial mobile health (mHealth) technologies, such as consumer-grade apps and wearable devices, offer opportunities for improving HF self-care, but their efficacy remains largely underexplored.

Objective

The objective of this study was to examine the feasibility, acceptability, safety, and preliminary efficacy of a patient-centered mHealth intervention (iCardia4HF) that integrates 3 consumer mHealth apps and devices (Heart Failure Health Storylines, Fitbit, and Withings) with a program of individually tailored SMS text messages to improve HF self-care.

Methods

We conducted a phase 1 randomized controlled trial. Eligible patients had stage C HF, were aged ≥40 years, and had New York Heart Association (NYHA) class I, II, or III HF. Patients were randomly assigned to either iCardia4HF plus usual care or to usual care only and were observed for 8 weeks. Key feasibility measures were recruitment and retention rates. The primary efficacy outcome was change in HF self-care subscale scores (maintenance, symptom perception, and self-care management) at 8 weeks, assessed with the Self-Care Heart Failure Index (SCHFI; version 7.2). Key secondary outcomes were modifiable behaviors targeted by the intervention (health beliefs, self-efficacy, and HF knowledge), health status, and adherence to daily self-monitoring of 2 core vital signs (body weight and blood pressure).

Results

A total of 27 patients were enrolled in the study and randomly assigned to iCardia4HF (n=13, 48%) or usual care (n=14, 52%). Of these 27 patients, 11 (41%) in the intervention group (iCardia4HF) and 14 (52%) in the usual care group started their assigned care and were included in the full analysis. Patients’ mean age was 56 (SD 8.3) years, 44% (11/25) were female, 92% (23/25) self-reported race as Black, 76% (19/25) had NYHA class II or III HF, and 60% (15/25) had HF with reduced left ventricular ejection fraction. Participant retention, completion of study visits, and adherence to using the mHealth apps and devices for daily self-monitoring were high (>80%). At 8 weeks, the mean group differences in changes in the SCHFI subscale scores favored the intervention over the control group: maintenance (Cohen d=0.19, 95% CI –0.65 to 1.02), symptom perception (Cohen d=0.33, 95% CI –0.51 to 1.17), and self-care management (Cohen d=0.25, 95% CI –0.55 to 1.04). The greatest improvements in terms of effect size were observed in self-efficacy (Cohen d=0.68) and health beliefs about medication adherence (Cohen d=0.63) and self-monitoring adherence (Cohen d=0.94). There were no adverse events due to the intervention. Conclusions iCardia4HF was found to be feasible, acceptable, and safe. A larger trial with a longer follow-up duration is warranted to examine its efficacy among patients with HF. Trial Registration ClinicalTrials.gov NCT03642275; https://clinicaltrials.gov/study/NCT03642275

Subjects

MeSH terms (MEDLINE)

Heart FailureSelf CareTelemedicinePatient-Centered CareHumansMaleFemaleMiddle AgedAgedChronic DiseaseMobile ApplicationsText Messaging

Author keywords

SMSappcardiologydigital healthheart failuremHealthrandomized controlled trialself-careself-managementsmartphonetelehealthtext messagingwearable electronic devices

Authors and institutions

  • University of Illinois Chicago, Chicago, IL, United States.
  • University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • Michigan State University, East Lansing, MI, United States.
  • Indiana University, Indianapolis, IN, United States.

ORCID profiles: Spyros Kitsiou, Ben S Gerber, Susan W Buchholz, Mayank M Kansal, Jiehuan Sun, Susan J Pressler

Funding

  • NIA NIH HHS
  • NCATS NIH HHS

Cite

APA

Kitsiou, S., Gerber, B. S., Buchholz, S. W., Kansal, M. M., Sun, J., & Pressler, S. J. (2025). Patient-Centered mHealth Intervention to Improve Self-Care in Patients With Chronic Heart Failure: Phase 1 Randomized Controlled Trial. Journal of Medical Internet Research, 27, e55586. https://doi.org/10.2196/55586

Vancouver

Kitsiou S, Gerber BS, Buchholz SW, Kansal MM, Sun J, Pressler SJ. Patient-Centered mHealth Intervention to Improve Self-Care in Patients With Chronic Heart Failure: Phase 1 Randomized Controlled Trial. Journal of Medical Internet Research. 2025;27:e55586. doi:10.2196/55586

BibTeX
@article{Kitsiou2025,
  author = {Kitsiou, Spyros and Gerber, Ben S and Buchholz, Susan W and Kansal, Mayank M and Sun, Jiehuan and Pressler, Susan J},
  title = {Patient-Centered mHealth Intervention to Improve Self-Care in Patients With Chronic Heart Failure: Phase 1 Randomized Controlled Trial},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  volume = {27},
  pages = {e55586},
  doi = {10.2196/55586}
}
Start for free →